Testing effectiveness (Phase 2)Ended earlyNCT04517435What this trial is testingME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Deepa Jagadeesh 13
Testing effectiveness (Phase 2)WithdrawnNCT05604417What this trial is testingZandelisib + Tazemetostat in R/R Follicular LymphomaWho this might be right forRelapsed Follicular LymphomaRefractory Follicular Lymphoma Jacob Soumerai, MD
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Early research (Phase 1)UnknownNCT05900089What this trial is testingEfficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell LymphomaWho this might be right forPeripheral T Cell Lymphoma Henan Cancer Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT02973191What this trial is testingDetermine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic LeukemiaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Celgene
Testing effectiveness (Phase 2)Study completedNCT00136474What this trial is testingAmifostine for Head and Neck Irradiation in LymphomaWho this might be right forLymphomaHodgkin's DiseaseNon-Hodgkin's Lymphoma Dana-Farber Cancer Institute 75
Early research (Phase 1)Study completedNCT01614197What this trial is testingA Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins LymphomaWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma Therapeutic Advances in Childhood Leukemia Consortium 16
Testing effectiveness (Phase 2)Ended earlyNCT00003113What this trial is testingOral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's LymphomasWho this might be right forLymphoma Case Comprehensive Cancer Center 6
Early research (Phase 1)Active Not RecruitingNCT04049513What this trial is testingENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)Who this might be right forLymphomas Non-Hodgkin's B-CellDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal B-cell Lymphoma (PMBCL)+3 more Malaghan Institute of Medical Research 30
Not applicableUnknownNCT05486013What this trial is testingZanubrutinib in the Treatment of Recurrent Refractory Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Peking University Third Hospital 30
Large-scale testing (Phase 3)UnknownNCT00499018What this trial is testingDose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell LymphomaIPI≥2 Fondazione Italiana Linfomi - ETS 399
Early research (Phase 1)Study completedNCT01878890What this trial is testingPhase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.Who this might be right forSolid TumorsNon-Hodgkin's Lymphoma Institut Bergonié 25
Early research (Phase 1)Study completedNCT03057418What this trial is testingOpen-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AuriхimWho this might be right forLymphoma, Non-HodgkinLymphoma, Follicular Biointegrator LLC 7
Testing effectiveness (Phase 2)UnknownNCT02481310What this trial is testingCombination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAdult Burkitt LymphomaB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaDiffuse Large B-Cell Lymphoma+2 more Northwestern University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06045910What this trial is testingA Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell MalignanciesWho this might be right forLymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell+3 more Cancer Research UK 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497What this trial is testingAssess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)Who this might be right forRelapsed or Refractory T-cell Lymphomas Bristol-Myers Squibb 85
Early research (Phase 1)Study completedNCT00412997What this trial is testingLBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell LymphomaWho this might be right forTumorsCutaneous T-Cell Lymphoma Novartis 14
Testing effectiveness (Phase 2)Study completedNCT00051597What this trial is testingA Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesWho this might be right forHodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more Seagen Inc. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04668690What this trial is testingClinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCLWho this might be right forPeripheral T Cell Lymphoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 193
Testing effectiveness (Phase 2)Looking for participantsNCT06826118What this trial is testingAxicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular LymphomaWho this might be right forLymphomaFollicular LymphomaRefractory Lymphoma The First Affiliated Hospital of Xiamen University 30